(Press-News.org) Knee and hip replacements are increasing globally due to an ageing population. In the United States, the number of patients needing a joint replacement will exceed 2.7 million in the next 7 years. Post-surgery infections, while rare at 1-5% of patients, result in high patient morbidity and mortality.
In the United States the annual national hospital costs for treating infection are projected to exceed $1.85 billion.
We currently use an antibiotic, cefazolin, at the time of surgery to prevent infection. But with the rise of antibiotic resistant bacteria, experts have debated whether adding a second antibiotic, vancomycin, would be better to prevent more infection. Vancomycin is a commonly used antibiotic for MRSA (methicillin resistant Staphylococcus aureus, or “golden Staph”). Many centres in Australia and globally had adopted the practice of giving both cefazolin and vancomycin to prevent infections, despite the lack of clear benefit.
Now a clinical trial, published today in the New England Journal of Medicine and led by Monash University researchers, in collaboration with orthopaedic surgeons and infectious diseases doctors, has found that the addition of vancomycin did not protect against infection and may have led to more infections and more adverse reactions for the patients.
According to the study lead, Professor Trisha Peel, from the Monash University Central Clinical School, “Given the number of joint replacements performed in Australia and globally, our trial has answered the important about whether more antibiotics are better for our patients having joint replacement surgery: with the definitive answer being “no”. This trial will have a significant impact on practice,” she said.
The Australian Surgical Antibiotic Prophylaxis (ASAP) trial looked at 4239 patients without a history of MRSA, in 11 hospitals across Australia, including regional and private hospitals. Patients were randomised to receive receive either vancomycin or saline placebo, in combination with cefazolin. Among all patients, the addition of vancomycin was no better than the traditional cefazolin antibiotic. Unexpectedly, in patients undergoing knee joint replacement, the risk of infection was higher in the vancomycin group, 5.7%, than in the placebo group, with 3.7% infection rate.
Professor Peel said that the study reflects how important these large, randomised, multi-centre clinical trials are “"A lot of things seem to make sense, but we don't really know for sure until they are tested in a clinical trial.” Prof Peel said “This is one of those cases - more antibiotics weren't better, and in some people might have actually been worse.",” she said.
END
More is not better: Trial finds giving more antibiotics to prevent joint replacement infections doesn't help
In joint replacement infection - vancomycin does not protect against infection and may lead to more infections
2023-10-18
ELSE PRESS RELEASES FROM THIS DATE:
Promising new options for treating aggressive prostate cancer
2023-10-18
Cedars-Sinai Cancer investigators have identified two promising new treatment options for men with recurrent prostate cancer—both of which helped patients live longer without their disease progressing than the current standard treatment. The results of their international Phase III clinical trial were published today in the New England Journal of Medicine.
“If these treatments are approved by the Food and Drug Administration, our results will be practice changing,” said Stephen Freedland, MD, associate director for Training and Education and the Warschaw, Robertson, ...
Liverpool chemist presented with 2023 Eni Energy Frontiers Award by President of Italy
2023-10-18
Professor Matt Rosseinsky, from the University of Liverpool’s Department of Chemistry and Materials Innovation Factory, was presented with the 2023 Eni Energy Frontiers Award by Sergio Mattarella, the President of the Republic of Italy, at a ceremony in Rome this week.
Professor Rosseinsky received the prestigious Eni Award for the digital design and discovery of next-generation energy materials.
The presentation ceremony took place at the Palazzo del Quirinale in Rome which was also attended by Giuseppe Zafarana, Chairman of Eni and Claudio Descalzi, CEO of Eni.
Professor Rosseinsky said: “It was a great honour to be presented with this award by the President ...
Study focusing on Black cancer survivors documents how exposure to racial discrimination impacts care
2023-10-18
The medical community has understood for some time that experiences with discrimination are bad for the health of people from underserved racial or ethnic groups — populations burdened with worse health outcomes than white patients for conditions including many cancers. The effects of chronic stress on the body have been considered one chief culprit.
Now, a research team from the Keck School of Medicine of USC and USC Norris Comprehensive Cancer Center, supported in part by the National Institutes of Health, has added new knowledge about how Black patients in particular are impacted by exposure to discrimination in the course of cancer care. Through interviews ...
Choosing exoskeleton settings like a Pandora radio station
2023-10-18
Images // Video
Taking inspiration from music streaming services, a team of engineers at the University of Michigan, Google and Georgia Tech has designed the simplest way for users to program their own exoskeleton assistance settings.
Of course, what's simple for the users is more complex underneath, as a machine learning algorithm repeatedly offers pairs of assistance profiles that are most likely to be comfortable for the wearer. The user then selects one of these two, and the predictor offers another ...
School discipline referrals for substance use increased in Oregon middle schools after legalization of recreational marijuana
2023-10-18
School Discipline Referrals for Substance Use Increased in Oregon Middle Schools after Legalization of Recreational Marijuana
A recent study found that Oregon middle school students received office discipline referrals (ODRs) for substance use offenses 30% more often after legalization of recreational marijuana relative to comparison schools in other states over the same period (school years 2012/2013 – 2018/2019). There were no statistically discernable changes in high school ODRs. Recreational use by adults was legalized in Oregon in 2015.
Researchers examined the extent to which legalization of recreational marijuana ...
UMass Amherst engineering professor is awarded $1.9 million to push the bounds of cancer, heart disease research
2023-10-18
UMass Amherst Engineering Professor Is Awarded $1.9 Million to Push the Bounds of Cancer, Heart Disease Research
Jinglei Ping will explore a new method of controlling cell communication by electronically regulating exosome traffic through the National Institutes of Health grant
AMHERST, Mass. — The human body is a sophisticated organism that has complex internal communication systems down to a cellular level. However, these systems transmit more than just messages about healthy human functions; they can also influence disease.
Consider cancer. Jinglei Ping poses the question: “How do unhealthy cells transport their own cancer ...
American Society of Anesthesiologists names Ronald L. Harter, M.D., FASA, new president
2023-10-18
SAN FRANCISCO — Ronald L. Harter, M.D., FASA, professor of anesthesiology in the Department of Anesthesiology at The Ohio State University Wexner Medical Center in Columbus, was today named president of the American Society of Anesthesiologists (ASA), the nation’s largest organization of physician anesthesiologists. Dr. Harter assumed office at the ANESTHESIOLOGY® 2023 annual meeting and will serve for one year.
“ASA is the premier educational, research and scientific organization representing anesthesiology in the U.S., and I’m honored to have this opportunity to advance ...
Study finds increased risk of Guillain-Barré after COVID-19 infection
2023-10-18
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, OCTOBER 18, 2023
MINNEAPOLIS – Having a COVID-19 infection is associated with an increased risk of developing the rare disorder called Guillain-Barré syndrome within the next six weeks, according to a study published in the October 18, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study also found that people who received the mRNA vaccine from Pfizer-BioNTech were less likely to develop the ...
Protecting polar bears aim of new and improved radar technology
2023-10-18
Research testing new technology to more effectively locate polar bear dens across the Arctic is showing promising results. Researchers from Simon Fraser University and Brigham Young University (BYU), collaborating with Polar Bears International, hope that improving detection tools to locate dens—which are nearly invisible and buried under snow—will help efforts to protect mother polar bears and their cubs.
Results of a pilot study aimed at improving den location in Churchill, Manitoba—using ARTEMIS Inc., an imaging system that relies on Synthetic Aperture Radar, or SAR—are published this week ...
From one nightmare to another. Anthony Fauci’s new concern
2023-10-18
(WASHINGTON) -- “What keeps you up at night?”
It’s a question Anthony Fauci, MD, heard repeatedly over the course of his nearly four decades as director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
Now a Distinguished University Professor at Georgetown University School of Medicine and the McCourt School of Public Policy, Fauci says he realized his worst nightmare -- a twist on the usual question -- in January 2020 when the type of virus he most feared triggered a worldwide pandemic.
Today, as the COVID-19 pandemic wanes, Fauci describes a new nemesis ...
LAST 30 PRESS RELEASES:
Global HIV study finds that cardiovascular risk models underestimate for key populations
New study offers insights into how populations conform or go against the crowd
Development of a high-performance AI device utilizing ion-controlled spin wave interference in magnetic materials
WashU researchers map individual brain dynamics
Technology for oxidizing atmospheric methane won’t help the climate
US Department of Energy announces Early Career Research Program for FY 2025
PECASE winners: 3 UVA engineering professors receive presidential early career awards
‘Turn on the lights’: DAVD display helps navy divers navigate undersea conditions
MSU researcher’s breakthrough model sheds light on solar storms and space weather
Nebraska psychology professor recognized with Presidential Early Career Award
New data shows how ‘rage giving’ boosted immigrant-serving nonprofits during the first Trump Administration
Unique characteristics of a rare liver cancer identified as clinical trial of new treatment begins
From lab to field: CABBI pipeline delivers oil-rich sorghum
Stem cell therapy jumpstarts brain recovery after stroke
Polymer editing can upcycle waste into higher-performance plastics
Research on past hurricanes aims to reduce future risk
UT Health San Antonio, UTSA researchers receive prestigious 2025 Hill Prizes for medicine and technology
Panorama of our nearest galactic neighbor unveils hundreds of millions of stars
A chain reaction: HIV vaccines can lead to antibodies against antibodies
Bacteria in polymers form cables that grow into living gels
Rotavirus protein NSP4 manipulates gastrointestinal disease severity
‘Ding-dong:’ A study finds specific neurons with an immune doorbell
A major advance in biology combines DNA and RNA and could revolutionize cancer treatments
Neutrophil elastase as a predictor of delivery in pregnant women with preterm labor
NIH to lead implementation of National Plan to End Parkinson’s Act
Growth of private equity and hospital consolidation in primary care and price implications
Online advertising of compounded glucagon-like peptide-1 receptor agonists
Health care utilization and costs for older adults aging into Medicare after the affordable care act
Reading the genome and understanding evolution: Symbioses and gene transfer in leaf beetles
Brains of people with sickle cell disease appear older
[Press-News.org] More is not better: Trial finds giving more antibiotics to prevent joint replacement infections doesn't helpIn joint replacement infection - vancomycin does not protect against infection and may lead to more infections